Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zika virus has pandemic potential, scientists say
aedes mosquito
"PAHO anticipates that Zika virus will continue to spread and will likely reach all countries and territories of the region where Aedes mosquitos are found."
Virus thought likely to spread across the Americas

The emerging mosquito-borne Zika virus now has 'explosive' pandemic potential, according to US scientists.

Since it was reported in Brazil in May last year, it has spread to 21 countries in the Americas (as of 23 January, 2016). This is of particular concern as there is growing evidence to suggest it could be linked with incomplete brain development in newborn babies.

It is primarily transmitted by Aedes mosquitoes, which are present in all of the Americas except Canada and continental Chile, meaning the virus is likely to spread further.

The Pan American Health Organization (PAHO) said in a statement: "PAHO anticipates that Zika virus will continue to spread and will likely reach all countries and territories of the region where Aedes mosquitos are found."

Another reason for its rapid spread, according to PAHO, is that it is new to the population of the Americas and therefore they have no immunity to it.

Whilst it generally causes only mild illness in humans, health authorities are currently investigating a possible link with microcephaly (abnormal smallness of the head) in babies.

Since Brazil reported the virus in 2015, there have been over 3,500 suspected cases - a 20-fold increase from 2010 through to 2014.

There is currently no vaccine for Zika virus. PAHO, which is a regional office of the World Health Organisation (WHO), says it is helping countries of the Americas to prepare for any possible spread through vector control, better surveillance and communication of prevention methods.

But scientists from Georgetown University, Washington DC, have said that lessons must be learnt from the Ebola epidemic. In July last year, the WHO Ebola Panel found that urgent warnings either failed to reach senior leaders, or senior leaders did not realise their significance.

Writing in the Journal of the American Medical Association, the team from Georgetown said that while the WHO has said it is supporting countries to control Zika, it 'is still not taking a leadership role in the Zika pandemic'.

An IHR emergency committee should be convened immediately, they added, saying that while Brazil, PAHO and the Centers for Disease Control have acted quickly, WHO headquarters have so far 'not been proactive'.

For the full study visit: http://jama.jamanetwork.com/article.aspx?articleID=2485361
For more information on Zika virus, see: http://www.who.int/mediacentre/factsheets/zika/en/

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.